SCNI

#5158
Scinai Immunotherapeutics Ltd. American Depositary Shares
0.5914 USD
-0.10%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
0.5901
0.5914
Intervallo Annuale
0.5500
1.0499
Variazione giornaliera
-0.10%
Variazione Mensile
-16.82%
Variazione di 6 mesi
-21.79%
Variazione Annuale
-21.79%
Chiusura Precedente
0.5920
Apertura
0.5901
Bid
Ask
Minimo
0.5901
High
0.5914
Volume
2
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 2.0511 M
  • Employee 31
  • Founded 2003
  • CEO N/A
  • Website www.scinai.com
  • Headquarter Israel
  • FIGI BBG007TGL1R2
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
791.22
Rapporto prezzo/fatturato
5 072.94

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

Notizie